Since Epstein, Achong, and Barr (1964) demonstrated the presence of a herpes-like virus (the EB virus) in cultured Burkitt tumour cells, many workers have investigated the significance of antibodies to this virus. Thus antibodies have been found in sera from patients with Burkitt tumours and in apparently normal individuals and, more recently, an association has been recognized between the development of antibodies to the EB virus and infection with infectious mononucleosis (Niederman, McCollum, Henle, and Henle, 1968) . Immunofluorescent techniques have been used in almost all these studies and complement-fixing antibodies, although described (Armstrong, Hlenle, and Henle, 1966; Gerber and Birch, 1967) , have not been employed to any great extent. In the following report, we outline our initial experience with a complement-fixing antigen prepared from cultured Burkitt tumour cells and suggest that this may provide an additional tool in the investigation of EB virus infections.
Methods
Sera were obtained from healthy medical students and nurses at the beginning of their hospital training, who also completed a questionnaire in which they were asked whether they had ever had infectious mononucleosis or glandular fever. In the present We followed up 23 patients who had been admitted to hospital, eight to 22 months previously, with infectious mononucleosis and who had remained well since their discharge from hospital. Significant increases in EB complement-fixation antibody levels were observed in almost all of these patients (Table V) . The EB complement-fixation antibody levels in medical students, nurses, and patients were analysed according to the time which had elapsed between the onset of infectious mononucleosis and the dates on which their sera were taken (Table VI) 
Discussion
It has been shown convincingly (zur Hansen, Henle, Hummeler, Diehl, and Henle, 1967; Epstein and Achong, 1968 ) that those cells which react in the 
